IeDEA International epidemiology Databases to Evaluate AIDS > Articles by: IeDEA

Author: IeDEA

‘Men – the elephant in the (gender & global health) room’

The recently established Lancet Commission on Gender and Global Health is delighted to announce a new fortnightly seminar series open to all. The Series accompanies the development of the Commission, inviting Commissioners and Co-Chairs to discuss a key topic, question, or challenge that the Commission hopes to tackle. The series aims to involve a range of stakeholders and voices in its work and promote discussion and debate on gender and health.

In the eleventh event of the series, Commissioner Morna Cornell, Senior Researcher & Project Manager, IeDEA-Southern Africa, highlighted the historical neglect of men in the response to HIV, and in public health more broadly.

https://youtu.be/2oTB4pnDlEE

Request for Applications – Fogarty-IeDEA Mentorship Program (FIMP)

The International Epidemiology Databases to Evaluate AIDS (IeDEA) is an international research consortium established in 2006 by the US National Institute of Allergy and Infectious Diseases to provide a rich resource for globally diverse HIV/AIDS data. The consortium consists of seven global regions: North America (NA-ACCORD); the Caribbean, Central and South America (CCASAnet); the Asia-Pacific; East Africa; Central Africa; West Africa; and Southern Africa. To date, the consortium houses data on over 2 million adults and 200,000 children and adolescents living with HIV. This wealth of data is an excellent resource for training new investigators. In collaboration with the Fogarty International Center (FIC), six IeDEA regions working in low- and middle-income countries have created training opportunities under the Fogarty IeDEA Mentorship Program (FIMP). Within each region, two 24-month mentee slots will be open to current and recent FIC D43 trainees, and IeDEA-affiliated investigators, for a total of 12 positions globally.

Applications Open: Monday, July 26th
Orientation Webinars: Week of August 9th
Applications due: Monday, October 25th

For more information continue reading here.

CROI 2022: Conference Overview and Details in Development

Mark the date: November 1, 2021, is the general abstract and scholarship submission deadline for the 29th Conference on Retroviruses and Opportunistic Infections (CROI). CROI 2022 will be held on February 13 to 16, 2022, and is currently planned as a hybrid conference to include both virtual and in-person participation. The in-person component, hosted in Denver, Colorado, USA, will feature additional sessions and networking opportunities for those attending live. The CROI Scientific Program Committee will monitor the COVID-19 pandemic carefully in terms of changes in the safety and practicality of hosting an in-person component.»

Adherence 2018 announcement

Adherence 2018 (13th International Conference on HIV Treatment and Prevention Adherence) will take place June 8-10, 2018, at the Loews Miami Beach Hotel in Miami, FL, USA. Sponsored by the International Association of Providers of AIDS Care (IAPAC), this annual series of conferences features the presentation and discussion of HIV treatment and biomedical prevention adherence research, as well as current behavioral and clinical perspectives in practicum, within the context of achieving an optimized continuum of HIV care and prevention. Continue reading “Adherence 2018 announcement”

CROI 2018 announcement

CROI 2018 will be held from March 4 to 7, 2018, in Boston, Massachusetts, at the Hynes Convention Center. Please note that CROI 2018 will be held from Sunday to Wednesday.

CROI has simplified and expanded the registration process, especially for abstract submitters (regardless of if the work was accepted).  They are increasing the limit on number of authors from 10 to 15, and allowing authors on non-accepted abstracts to register before we open for general registration. They are particularly interested in encouraging new investigators to submit to and attend CROI.

Abstract deadline is Sep 27, per slide.

Important Dates and Details

  •  September 27: General Abstract Submission Closes
  •  January 16: Late Breaking Abstract Submission Closes
  •  New Next year: easier and earlier access to registration for   Abstract Submitters and their collaborators

More details at: www.CROIconference.org

*CROI begins on a Sunday next year

16th International Conference on Malignancies in HIV/AIDS

The NCI invites to join us at the 16th International Conference on Malignancies in HIV/AIDS (ICMH) previously named the International Conference on Malignancies  in AIDS and Other Acquired Immunodeficiencies (ICMAOI). The meeting will take place October 23-24, 2017, at the Lister Hill Center Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland.

This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services.

Recent advances in areas such as viral oncology, immunology, genetics, epidemiology, pathogenesis, early diagnosis, and clinical investigation of malignant diseases associated with HIV and other acquired immunodeficiency states will be shared at this conference. Our objective is to facilitate the exchange of information between laboratory and clinical researchers so as to accelerate the translation of basic scientific discoveries into clinical applications.

Registration and further information on
http://event.capconcorp.com/wp/imc-aids/

 

Prevent HIV, test and treat all – WHO support for country impact Progress report 2016

World AIDS Day is 1st December each year, an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV and to commemorate people who have died.

This year, during the same week the WHO launched their 2016 global HIV progress report alongside their updated guidelines on HIV self-testing and partner notification.

Several IeDEA-WHO collaboration analyses from both the 2015 and 2016 rounds of this collaboration were cited in chapter three (Country action and WHO support) of this latest WHO progress report (see pages 28-30 & 38). Many thanks to the IeDEA teams for your continued commitment and support of this evolving and expanding collaboration with WHO.